Direct oral anticoagulants: still new perspectives after one decade of innovation

Organized with the participation of Bayer

Jeudi 18 Janvier 2018   10:30-12:00   Blue Amphitheatre
Symposium (organized with the participation of Industry)
Atrial fibrillation and coronary artery disease: a new paradigm
10:50 • Olivier Hanon
Atrial fibrillation: a reflexion of French practices
11:10 • Gilbert Deray
Atrial fibrillation and renal impairment: how to tailor the management?
11:30 • Nicolas Meneveau
Venous thromboembolic disease: long term prevention of recurrences